A Deep Dive into Innovation and Adaptability and its Effect on the Healthcare Workforce

 

The healthcare sector has been going through a significant period of disruption, especially since the onset of the COVID-19 pandemic. Millions of healthcare workers have had to adapt to new technologies and workflows, while simultaneously dealing with the direct impacts of the pandemic. In all, the healthcare workforce has greatly been impacted. With an industry that employs over 22 million people in the U.S. alone, the stakes are incredibly high.

So, what does this mean for the healthcare workforce, and how are industry professionals coping with the changes? This critical question forms the basis for a fascinating new conversation in the inaugural episode of “DisruptEd: Healthcare Edition.”

In the debut episode, host Ron Stefanski discusses the impacts of disruption in the healthcare workforce with co-host Larry Yuhasz, the Principal at LS Yuhasz Consulting, as they unveil a new perspective on the adaptability and future of the healthcare industry.

 

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…